Henlius partners with Sandoz for 10 biosimilar antibodies
Biotechnology company Henlius entered a strategic collaboration with Sandoz on 17 August 2026 covering up to 10 proposed monoclonal antibody biosimilars for global distribution
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.